/Investor DB

SBI Investment — 2019 Investments

3 investments dated 2019 · listed companies and verified rows first · show all

Atonarpatonarp.comAug 2019

A company that manufactures mass spectrometry instruments for semiconductor and freeze-drying process monitoring and control at the molecular level.

Advanced ManufacturingAI & Machine LearningDeep TechHardwareSemiconductorsTokyo, JP

Sridhar Marcy Prakash(Founder, President and CEO)

Co-investorsCelesta CapitalGlobal Hands-On VCOpen Field CapitalINCJ, Ltd.Japan Post Investment

Satsuma Pharmaceuticalssatsumarx.comApr 2019 · $62M

Satsuma Pharmaceuticals develops therapeutics for the acute treatment of migraine, including an approved dihydroergotamine nasal powder product (Atzumi/STS101).

BiotechHealthtechMedical DevicesSouth San Francisco, US

John Kollins(Executive Officer, Director)Tadayoshi Iwashima(Executive Officer)Thomas B. King(President and Board Director)inRob Janosky(Chief Commercial Officer)Tom O'Neil(Chief Financial Officer)inDavid Prichard(Chief Operating Officer)

Co-investorsOUP (Osage University Partners)Vivo CapitalWellington ManagementLumira VenturesRA CapitalRed Tree Venture

Yoriso Co., Ltd.yoriso.comSep 2019

Japanese end-of-life services company that connects bereaved families to funeral homes and Buddhist monk-dispatch services online.

Tokyo, JP

芦沢 雅治(代表取締役 (Representative Director))Masaharu Ashizawain篠﨑 新悟(代表取締役 (Representative Director))

Co-investorsAG Capital Co. Ltd.Global BrainGlobis Capital PartnersSony Ventures CorporationAG CapitalCygames Capital+5 more

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.